Alivus Life Sciences Ltd(BSE:ALIVUS)

{{price.price}} INR

{{price.change}}%

：{{price.high}}	：2147	：4.51%	：43.15
：{{price.low}}	：1955917	：21.11%	：1259
：{{price.open}}	：-0.18%	：21.38%	：827
：{{price.close}}	：-0.03	：10670260000%	：111768843065

3.59	1.21	-3.05	-7.81
-9.19	-9.07	21.29	21.29
0.77	2.14	2.39	2147
15133	1745594	符号详情：1天涨跌率 -0.18	2.37
1.65	-1	21	14
912	871	897	173925.6
76725.93	45203.25	32085.76	1.47
-0.03	-2.12	0.15	0.01
0.06	9.91	847	847
847	369	827	933
1078	1103	1335	1259
39.63	43.27	4856270000	5303890000
2542260000	7638460000	10670260000	9.65
10.58	39.52	43.15	6735930000
23718930000	24812150000
			2452330000
	-5923520000	30153560000
191770000	712360000	6527970000	5488510000
24759470000	6013960000	4893260000	4893260000
604450000	36383430000	105845323065	17.15

			20.47
21.38	32.2	43	18.86
19.1	26.18	27.15

Alivus Life Sciences Ltd. engages in the provision of development and manufacture of non-commoditized active pharmaceutical ingredients. It operates through the Within India and Outside India geographical segments. Its products focus on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.

： http://www.glenmarklifesciences.com

：Yasir Rawjee

：2011

：Mumbai

：Health technology

：Pharmaceuticals: major